Viewing Study NCT01700751


Ignite Creation Date: 2025-12-24 @ 11:44 PM
Ignite Modification Date: 2026-01-05 @ 11:57 AM
Study NCT ID: NCT01700751
Status: COMPLETED
Last Update Posted: 2019-04-16
First Post: 2012-09-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Brentuximab Vedotin Prevention of (GVHD) After Unrelated Allogeneic Stem Cell Transplantation
Sponsor: Washington University School of Medicine
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module